|
1
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J,
Lee J, Provost P, Rådmark O, Kim S, et al: The nuclear RNase III
Drosha initiates microRNA processing. Nature. 425:415–419. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lund E, Güttinger S, Calado A, Dahlberg JE
and Kutay U: Nuclear export of microRNA precursors. Science.
303:95–98. 2004. View Article : Google Scholar
|
|
4
|
Bracken CP, Khew-Goodall Y and Goodall GJ:
Network-Based Approaches to Understand the Roles of miR-200 and
Other microRNAs in Cancer. Cancer Res. 75:2594–2599. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lujambio A and Lowe SW: The microcosmos of
cancer. Nature. 482:347–355. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Iorio MV, Piovan C and Croce CM: Interplay
between microRNAs and the epigenetic machinery: An intricate
network. Biochim Biophys Acta. 1799:694–701. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Viré E, Brenner C, Deplus R, Blanchon L,
Fraga M, Didelot C, Morey L, Van Eynde A, Bernard D, Vanderwinden
JM, et al: The Polycomb group protein EZH2 directly controls DNA
methylation. Nature. 439:871–874. 2006. View Article : Google Scholar
|
|
8
|
Sakurai T, Bilim VN, Ugolkov AV, Yuuki K,
Tsukigi M, Motoyama T and Tomita Y: The enhancer of zeste homolog 2
(EZH2), a potential therapeutic target, is regulated by miR-101 in
renal cancer cells. Biochem Biophys Res Commun. 422:607–614. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Alajez NM, Shi W, Hui AB, Bruce J,
Lenarduzzi M, Ito E, Yue S, O'Sullivan B and Liu FF: Enhancer of
Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal
carcinoma and is regulated by miR-26a, miR-101, and miR-98. Cell
Death Dis. 1:e852010. View Article : Google Scholar
|
|
10
|
Zhang JG, Guo JF, Liu DL, Liu Q and Wang
JJ: MicroRNA-101 exerts tumor-suppressive functions in non-small
cell lung cancer through directly targeting enhancer of zeste
homolog 2. J Thorac Oncol. 6:671–678. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cho HM, Jeon HS, Lee SY, Jeong KJ, Park
SY, Lee HY, Lee JU, Kim JH, Kwon SJ, Choi E, et al: microRNA-101
inhibits lung cancer invasion through the regulation of enhancer of
zeste homolog 2. Exp Ther Med. 2:963–967. 2011.
|
|
12
|
Ren G, Baritaki S, Marathe H, Feng J, Park
S, Beach S, Bazeley PS, Beshir AB, Fenteany G, Mehra R, et al:
Polycomb protein EZH2 regulates tumor invasion via the
transcriptional repression of the metastasis suppressor RKIP in
breast and prostate cancer. Cancer Res. 72:3091–3104. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Au SL, Wong CC, Lee JM, Fan DN, Tsang FH,
Ng IO and Wong CM: Enhancer of zeste homolog 2 epigenetically
silences multiple tumor suppressor microRNAs to promote liver
cancer metastasis. Hepatology. 56:622–631. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cao Q, Mani RS, Ateeq B, Dhanasekaran SM,
Asangani IA, Prensner JR, Kim JH, Brenner JC, Jing X, Cao X, et al:
Coordinated regulation of polycomb group complexes through
microRNAs in cancer. Cancer Cell. 20:187–199. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu JJ, Lin XJ, Yang XJ, Zhou L, He S,
Zhuang SM and Yang J: A novel AP-1/miR-101 regulatory feedback loop
and its implication in the migration and invasion of hepatoma
cells. Nucleic Acids Res. 42:12041–12051. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zheng F, Liao YJ, Cai MY, Liu TH, Chen SP,
Wu PH, Wu L, Bian XW, Guan XY, Zeng YX, et al: Systemic delivery of
microRNA-101 potently inhibits hepatocellular carcinoma in vivo by
repressing multiple targets. PLoS Genet. 11:e10048732015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guo J, Cai J, Yu L, Tang H, Chen C and
Wang Z: EZH2 regulates expression of p57 and contributes to
progression of ovarian cancer in vitro and in vivo. Cancer Sci.
102:530–539. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li Y, Xie J, Xu X, Wang J, Ao F, Wan Y and
Zhu Y: MicroRNA-548 down-regulates host antiviral response via
direct targeting of IFN-λ1. Protein Cell. 4:130–141. 2013.
View Article : Google Scholar
|
|
19
|
Ha M and Kim VN: Regulation of microRNA
biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Krol J, Loedige I and Filipowicz W: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet. 11:597–610. 2010.PubMed/NCBI
|
|
21
|
Qin LX, Tang ZY, Sham JS, Ma ZC, Ye SL,
Zhou XD, Wu ZQ, Trent JM and Guan XY: The association of chromosome
8p deletion and tumor metastasis in human hepatocellular carcinoma.
Cancer Res. 59:5662–5665. 1999.PubMed/NCBI
|
|
22
|
Leung TH, Wong N, Lai PB, Chan A, To KF,
Liew CT, Lau WY and Johnson PJ: Identification of four distinct
regions of allelic imbalances on chromosome 1 by the combined
comparative genomic hybridization and microsatellite analysis on
hepatocellular carcinoma. Mod Pathol. 15:1213–1220. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Patil MA, Gütgemann I, Zhang J, Ho C,
Cheung ST, Ginzinger D, Li R, Dykema KJ, So S, Fan ST, et al:
Array-based comparative genomic hybridization reveals recurrent
chromosomal aberrations and Jab1 as a potential target for 8q gain
in hepatocellular carcinoma. Carcinogenesis. 26:2050–2057. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brabletz T: MiR-34 and SNAIL: Another
double-negative feedback loop controlling cellular plasticity/EMT
governed by p53. Cell Cycle. 11:215–216. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Luzi E, Marini F, Giusti F, Galli G,
Cavalli L and Brandi ML: The negative feedback-loop between the
oncomir Mir-24-1 and menin modulates the Men1 tumorigenesis by
mimicking the 'Knudson's second hit'. PLoS One. 7:e397672012.
View Article : Google Scholar
|
|
26
|
Yamakuchi M and Lowenstein CJ: MiR-34,
SIRT1 and p53: The feedback loop. Cell Cycle. 8:712–715. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bachmann HS, Siffert W and Frey UH:
Successful amplification of extremely GC-rich promoter regions
using a novel 'slowdown PCR' technique. Pharmacogenetics.
13:759–766. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Frey UH, Bachmann HS, Peters J and Siffert
W: PCR-amplification of GC-rich regions: 'Slowdown PCR'. Nat
Protoc. 3:1312–1317. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li LY, Li Q, Yu YH, Zhong M, Yang L, Wu
QH, Qiu YR and Luo SQ: A primer design strategy for PCR
amplification of GC-rich DNA sequences. Clin Biochem. 44:692–698.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim VN, Han J and Siomi MC: Biogenesis of
small RNAs in animals. Nat Rev Mol Cell Biol. 10:126–139. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Davis-Dusenbery BN and Hata A: Mechanisms
of control of microRNA biogenesis. J Biochem. 148:381–392.
2010.PubMed/NCBI
|
